Anne Kirby
Keine laufenden Positionen mehr
Vermögen: - $ am 30.09.2023
Profil
Anne Kirby served as the President, CEO, Secretary & Director at Regnum Corp.
from 2021 to 2023.
Prior to that, she was the Executive Vice President-Commercial & Operations at Vyera Pharmaceuticals LLC from 2018 to 2021.
Ms. Kirby received her undergraduate degree in 2002 and her MBA in 2004 from the University of Akron.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
REGNUM CORP.
-.--% | 11.04.2023 | 0 ( -.--% ) | - $ | 30.09.2023 |
Ehemalige bekannte Positionen von Anne Kirby
| Unternehmen | Position | Ende |
|---|---|---|
| REGNUM CORP. | Vorstandsvorsitzender | 23.05.2023 |
Vyera Pharmaceuticals LLC
 Vyera Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vyera Pharmaceuticals LLC operates as a biopharmaceutical company that focuses on patients with unmet medical needs. Its products include Vecamyl and Daraprim. The firm engages in developing and commercializing treatments for serious diseases and conditions of therapeutic areas. The company was founded by Martin Shkreli in October 10, 2014 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.04.2021 |
Ausbildung von Anne Kirby
| University of Akron | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| REGNUM CORP. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Vyera Pharmaceuticals LLC
Vyera Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vyera Pharmaceuticals LLC operates as a biopharmaceutical company that focuses on patients with unmet medical needs. Its products include Vecamyl and Daraprim. The firm engages in developing and commercializing treatments for serious diseases and conditions of therapeutic areas. The company was founded by Martin Shkreli in October 10, 2014 and is headquartered in New York, NY. | Health Technology |
